Pulmonx (LUNG) Earnings Date, Estimates & Call Transcripts

$7.31

+0.37 (+5.33%)

(As of 09/6/2024 ET)

LUNG Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

LUNG Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Ad Weiss Ratings

“Fed Proof” Your Bank Account with THESE 4 Simple Steps

Starting as soon as a few months from now, the United States government will make a sweeping change to bank accounts nationwide. It will give them unprecedented powers to control your bank account.

Learn these 4 simple steps and protect your savings before it’s too late.

Pulmonx Analyst EPS Estimates

Current Year EPS Consensus Estimate:($1.64) EPS
Next Year EPS Consensus Estimate: ($1.63) EPS

LUNG Earnings Date and Information

Pulmonx has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Monday, November 4th, 2024 based off prior year's report dates.

Pulmonx Earnings History by Quarter

Time Frame

Start Date

End Date

Export to Excel

Date	Quarter	Consensus Estimate	Reported EPS	Beat/Miss	GAAP EPS	Revenue Estimate	Actual Revenue
11/4/2024 (Estimated)	-	-	-	-	-	-	-
5/1/2024	Q1 2024	($0.43)	($0.36)	+$0.07	($0.36)	$17.54 million	$18.85 million
2/21/2024	Q4 2023	($0.38)	($0.36)	+$0.02	($0.36)	$18.24 million	$19.30 million
10/30/2023	Q3 2023	($0.45)	($0.39)	+$0.06	($0.39)	$16.67 million	$17.67 million
8/2/2023	Q2 2023	($0.43)	($0.43)	-	($0.43)	$15.86 million	$17.20 million
5/2/2023	Q1 2023	($0.43)	($0.42)	+$0.01	($0.42)	$13.49 million	$14.50 million
2/22/2023	Q4 2022	($0.41)	($0.38)	+$0.03	($0.38)	$13.98 million	$15.40 million
Get the Latest News and Ratings for LUNG and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Pulmonx and its competitors with MarketBeat's FREE daily newsletter.
11/3/2022	Q3 2022	($0.40)	($0.38)	+$0.02	($0.38)	$14.91 million	$13.50 million
8/2/2022	Q2 2022	($0.41)	($0.40)	+$0.01	($0.40)	$13.71 million	$13.95 million
5/3/2022	Q1 2022	($0.37)	($0.43)	($0.06)	($0.43)	$9.26 million	$10.79 million
2/23/2022	Q4 2021	($0.35)	($0.35)	-	($0.35)	$14.24 million	$13.71 million
11/1/2021	Q3 2021	($0.37)	($0.28)	+$0.09	($0.28)	$13.36 million	$13.26 million
8/2/2021	Q2 2021	($0.37)	($0.34)	+$0.03	($0.34)	$10.26 million	$12.20 million
5/3/2021	Q1 2021	($0.39)	($0.34)	+$0.05	($0.34)	$8.18 million	$9.24 million
3/1/2021	Q4 2020	($0.28)	($0.27)	+$0.01	($0.27)	$8.70 million	$9.83 million
11/15/2020	Q3 2020	($4.32)	($2.26)	+$2.06	($1.37)	$8.00 million	$10.61 million

Pulmonx Earnings - Frequently Asked Questions

When is Pulmonx's earnings date?: Pulmonx has not confirmed its next earnings publication date, but the company's estimated earnings date is Monday, November 4th, 2024 based off last year's report dates. Learn more on LUNG's earnings history.
What guidance has Pulmonx issued on next quarter's earnings?: Pulmonx updated its FY 2024 earnings guidance on Wednesday, July, 31st. The company issued revenue guidance of $81.0 million-$84.0 million, compared to the consensus revenue estimate of $82.6 million.
How much revenue does Pulmonx generate each year?: Pulmonx (NASDAQ:LUNG) has a recorded annual revenue of $76.58 million.
How much profit does Pulmonx generate each year?: Pulmonx (NASDAQ:LUNG) has a recorded net income of -$60.84 million. LUNG has generated -$1.54 earnings per share over the last four quarters.
What is Pulmonx's EPS forecast for next year?: Pulmonx's earnings are expected to grow from ($1.64) per share to ($1.63) per share in the next year.